These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34744006)

  • 1. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.
    Medha ; Priyanka ; Sharma S; Sharma M
    Eur J Pharm Sci; 2022 Jan; 168():106051. PubMed ID: 34744006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
    Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
    Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules.
    Saraav I; Pandey K; Sharma M; Singh S; Dutta P; Bhardwaj A; Sharma S
    Infect Genet Evol; 2016 Oct; 44():182-189. PubMed ID: 27389362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.
    Sayes F; Pawlik A; Frigui W; Gröschel MI; Crommelynck S; Fayolle C; Cia F; Bancroft GJ; Bottai D; Leclerc C; Brosch R; Majlessi L
    PLoS Pathog; 2016 Jul; 12(7):e1005770. PubMed ID: 27467705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of multi-epitope based vaccine against
    Nayak SS; Sethi G; Ramadas K
    J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates.
    Madan R; Pandit K; Bhati L; Kumar H; Kumari N; Singh S
    Microb Pathog; 2021 Aug; 157():104996. PubMed ID: 34044044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine potential of ESAT-6 protein fused with consensus CD4
    Choi SY; Kwon KW; Kim H; Choi HH; Shin SJ
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2195-2201. PubMed ID: 29894686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
    Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
    J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR.
    Shiraz M; Lata S; Kumar P; Shankar UN; Akif M
    Infect Genet Evol; 2021 Oct; 94():105017. PubMed ID: 34332157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.
    Pandey K; Sharma M; Saarav I; Singh S; Dutta P; Bhardwaj A; Sharma S
    Int J Mycobacteriol; 2016 Mar; 5(1):34-43. PubMed ID: 26927988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
    Nain Z; Karim MM; Sen MK; Adhikari UK
    Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against
    Kumar A; Sharma P; Arun A; Meena LS
    J Biomol Struct Dyn; 2023 May; 41(8):3382-3404. PubMed ID: 35293852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis.
    Sethi G; Varghese RP; Lakra AK; Nayak SS; Krishna R; Hwang JH
    Sci Rep; 2024 Jul; 14(1):15923. PubMed ID: 38987613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and evaluation of immunogenic MHC-I and MHC-II binding peptides from Mycobacterium tuberculosis.
    Jagadeb M; Pattanaik KP; Rath SN; Sonawane A
    Comput Biol Med; 2021 Mar; 130():104203. PubMed ID: 33450502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential.
    Sayes F; Sun L; Di Luca M; Simeone R; Degaiffier N; Fiette L; Esin S; Brosch R; Bottai D; Leclerc C; Majlessi L
    Cell Host Microbe; 2012 Apr; 11(4):352-63. PubMed ID: 22520463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17.
    Moodley A; Fatoba A; Okpeku M; Emmanuel Chiliza T; Blessing Cedric Simelane M; Pooe OJ
    Immunol Res; 2022 Aug; 70(4):501-517. PubMed ID: 35554858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines.
    Medha ; Bhatt P; Priyanka ; Sharma M; Sharma S
    In Silico Pharmacol; 2021; 9(1):40. PubMed ID: 34221846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis.
    Devasundaram S; Deenadayalan A; Raja A
    Immunol Invest; 2014; 43(2):137-59. PubMed ID: 24467664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis.
    Arega AM; Dhal AK; Pattanaik KP; Nayak S; Mahapatra RK
    Appl Biochem Biotechnol; 2024 Apr; 196(4):2367-2395. PubMed ID: 37498378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.